Review Article

The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood

Table 1

Publications on major histocompatibility class II human leukocyte antigens and their association with primary sclerosing cholangitis patients.

ReferenceTotal number of patients/controls (number of children and adolescents)What was evaluatedConclusions

Farrant et al. [32], 1992
71/68 (0)HLADRB, DQA, and DQBHLADRB30101 was the most associated allele, with reduced survival of patients with it. DRB50101 was another susceptibility allele and DRB40101 demonstrated a likely protective function.

Amar et al. [33], 1992
15/no control (0)HLADRB3No apparent association of the alleles of the DRB3 locus in the Israeli population.

Olerup et al. [34], 1995
75/250 (not cited)HLADR and DQAssociation with DRB11301, DQAI0103, and DQBI0603 haplotype was confirmed, whereas DRB104 was only slightly underrepresented.
No difference was observed in age, presentation, liver function, histological stage, or survival between patients with different positive alleles.

Leidenius et al. [35], 199524/106 (not cited)HLA-A, B, C and DRHLA-B8 and DR3 (DRB103) were associated with primary sclerosing cholangitis.

Wilschanski et al. [36], 199527/no control (all children)HLA-B and HLADRAn increased incidence of HLA B8 and DR2 (DRB115) but not DRw52a (DRB30101) was found.

Spurkland et al. [30], 1999
256/764 (not cited)HLADR and DQIncreased frequencies of DRB103-DQA10501-DQB102, DRB113-DQA10103-DQB10603, and DRB115-DQA10102-DQB10602 haplotypes were observed.
PSC was negatively associated with DRB104-DQB10302 haplotype.

Boberg et al. [37], 2001
265/no control (yes, but the number was not cited)HLADR and DQDRB103-DQA10501-DQB102 (i.e., DR3, DQ2) heterozygous genotype was associated with an increased risk of death or liver transplantation.
Presence of a DQ6 encoding haplotype (DQB10603 or DQB10602) in DR3, DQ2 negative individuals was associated with a reduced risk of death or liver transplantation.

Donaldson and Norris [31], 2002
148/134 (0)HLADR and DQAssociations with the DRB30101-DRB10301-DQA10501-DQB10201 and DRB11301-DQA10103-DQB10603 haplotypes were confirmed.
Protective influence of the DRB104-DQB10302 haplotype was reaffirmed.
A previously unreported protective haplotype was found: DRB10701-DQB10303.

Bittencourt et al. [38], 2002
63/83 (27)HLA-B, DRB1, DQB1No increase in the frequency of HLA-B, DRB3, DRB4, or DRB5 alleles was observed.
The frequency of HLA-DRB11301 and HLA-DQB106 was significantly increased in PSC patients.

Neri et al. [39], 200364/183 (0)HLA-DRB1, HLA-DQB1, and HLA-BFrequencies of DRB101-DQA10101-DQB10102, DRB116-DQA10102-DQB10502, and DRB104-DQA103-DQB10301 haplotypes were more elevated in PSC patients.
DRB107-DQA10201-DQB102 haplotype frequency was significantly decreased in patients.

Karlsen et al. [25], 2010
285/298 (yes, but the number was not cited)HLADR and DQThe strongest association was detected for HLA-B08 and associations with the DRB1 alleles -DRB103, -DRB104, -DRB107, and -DRB11301 also were confirmed.

Hov et al. [40], 2010
78/79 (not cited)HLADRB1, HLA-CPositive association of PSC with HLADRB115,
-DRB103, -DRB104, and
-DRB11301 was confirmed.
A protective association with HLADRB10701 was found.

Wang et al. [41], 2014
31/42 (all children)HLADR haplotypesFrequencies of homozygous HLA DRB10301 (DR3) genes and haplotype A1-B8-DR3 were higher in patients.
Frequencies of disease-protective genes DR4 and/or DR15 were lower in the patients.

Næss et al. [42], 2014
365/368 (yes, but the number was not cited)HLADRB11301-DQB10603 and DRB11501 haplotypes conferred risk for PSC.
HLADRB104-DQB103, DRB10701-DQ0303, and DR13:XX (all non-13:01 alleles)-DQB106 demonstrated a protective effect.

HLA: human leukocyte antigen; MHC: major histocompatibility complex; PSC: primary sclerosing cholangitis.